Nanox Announces Revised Time of Live Demonstration at the 2020 Radiology Society of North America Virtual Annual Meeting Nanox Announces Revised Time of Live Demonstration at the 2020 Radiology Society of North America Virtual Annual Meeting
Live demonstration now scheduled for 11:30am EST on Thursday, December 3 Company to host investor…
Ceapro Inc. Reports 2020 Third Quarter and Nine-Month Financial Results and Operational Highlights
– R&D activities focused on advancing the development of innovative delivery systems and yeast beta…
USAN Modifies Lead Drug Candidate’s Chemical Name to ‘Simufilam’
Future References to Lead Drug Candidate for Alzheimer’s Disease Will Be Simufilam AUSTIN, Texas, Nov….
CEO Dr. Shankar Musunuri to be Featured as a Panelist at Xconomy’s Xcelerating Life Sciences Virtual Event Discussing The Promise of Cell & Gene Therapies
MALVERN, Pa., Nov. 27, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company…
DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies
Initial funding of up to $34 million for the project “Gene Mabs: A Scalable, Economic,…
Phathom Pharmaceuticals to Participate at Upcoming Investor Healthcare Conferences
FLORHAM PARK, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a…
Spectral Medical to Host Virtual Investor Day on December 4, 2020
TORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
IMCIVREE™(setmelanotide) Logo Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™(setmelanotide) as First-ever Therapy for Chronic Weight…
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
Biogen and Sage enter into an agreement to jointly develop and commercialize zuranolone and SAGE-324…
Policy thought-leaders, Don Drummond and Duncan Sinclair, release long-term care report seeking to reshape the future for Canadian seniors
KINGSTON, Ontario, Nov. 27, 2020 (GLOBE NEWSWIRE) — Today, renowned public policy experts Don Drummond…